OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The way of SARS-CoV-2 vaccine development: success and challenges
Yetian Dong, Tong Dai, Bin Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 50

Showing 26-50 of 50 citing articles:

Mapping monoclonal anti-SARS-CoV-2 antibody repertoires against diverse coronavirus antigens
Matheus Oliveira de Souza, Bharat Madan, I‐Ting Teng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5

Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression
Maria Razzaq, Ji Ho Han, Subramaniyam Ravichandran, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 7, pp. 598-615
Closed Access | Times Cited: 2

Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review
Guanjian Li, Rongqiu Zhang, Bing Song, et al.
JMIR Public Health and Surveillance (2023) Vol. 9, pp. e48511-e48511
Open Access | Times Cited: 2

NMR 1H,19F-based screening of the four stem-looped structure 5_SL1–SL4 located in the 5′-untranslated region of SARS-CoV 2 RNA
Daniel Hymon, Jason Martins, Christian Richter, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 165-177
Open Access | Times Cited: 2

Ecological comparison of six countries in two waves of COVID-19
Meiheng Liu, Leiyu Shi, Manfei Yang, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access

The effect ofCitrus reticulatapeel extract containing hesperidin on inhibition of SARS-CoV-2 infection based on pseudovirus entry assays
Endah Puji Septisetyani, Hayfa Salsabila Harsan, Dennaya Kumara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein
Sara Piacentini, Anna Riccio, Silvia Santopolo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3

Optimization of potential non-covalent inhibitors for the SARS-CoV-2 main protease inspected by a descriptor of the subpocket occupancy
Yujia Sun, Bodi Zhao, Yuqi Wang, et al.
Physical Chemistry Chemical Physics (2022) Vol. 24, Iss. 48, pp. 29940-29951
Closed Access | Times Cited: 3

BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study
Jorge Hernández‐Bello, José Julio Sierra-García-de-Quevedo, José Javier Morales‐Núñez, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1127-1127
Open Access | Times Cited: 1

A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine
Glenis Scadding
Frontiers in Allergy (2022) Vol. 3
Open Access | Times Cited: 2

Perspective Technologies of Vaccination: Do We Still Need Old Vaccines?
Maria Isaguliants, Felicity J. Burt
Vaccines (2022) Vol. 10, Iss. 6, pp. 891-891
Open Access | Times Cited: 2

Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2

The response to the COVID-19 pandemic trusted in pharmacovigilance to diminish communication risk
Gustavo A. Quintero
Therapeutic Advances in Drug Safety (2022) Vol. 13
Open Access | Times Cited: 1

Genomic evolution of the SARS-CoV-2 Variants of Concern: COVID-19 pandemic waves in India.
Pooja Bhardwaj, Shailendra Kumar Mishra, Sthita Pragnya Behera, et al.
PubMed (2023) Vol. 22, pp. 451-465
Closed Access

Electrogenic Staphylococcus epidermidis colonizes nasal cavities and alleviates IL-6 progression induced by the SARS2-CoV nucleocapsid protein
Enkhbat Zayabaatar, Nguyen Mai Trinh Tang, M.T. Pham
Journal of Applied Microbiology (2023) Vol. 134, Iss. 8
Closed Access

Produksi Antibodi Poliklonal Menggunakan Protein Rekombinan RBD-spike Untuk Deteksi SARS-CoV-2
Iryani Endah Febrianti, Yayuk Fatmawati, Intan Ria Neliana, et al.
AL-Kauniyah Jurnal Biologi (2023) Vol. 16, Iss. 2, pp. 336-346
Open Access

Efektivitas Vaksinasi terhadap Infeksi Covid-19 Pada Anak-Anak: Systematic Review
Adinda Juwita Syakila Elizafanti, Fasha Rudilla Putri, Luwes Sekar Ayu Wardhani, et al.
Syntax Literate Jurnal Ilmiah Indonesia (2022) Vol. 7, Iss. 1, pp. 46-46
Open Access

Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants
Anna R. Mäkelä, Hasan Uğurlu, Liina Hannula, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access

Previous Page - Page 2

Scroll to top